# Phase 0 Reviewer Handoff

_Last updated: 2025-02-14_

## Completed Scope
- Package scaffold ready: modules importable under `src/meteor_darkflight/`.
- Development environment documented (`README.md` quickstart for Python 3.12 + venv).
- Core tooling configured and exercised:
  - `ruff check`
  - `mypy src`
  - `pytest`
- CLI validation flow implemented (`python -m meteor_darkflight.cli_api.cli validate`).
- Canonical data artifacts established:
  - Templates (`docs/templates/`)
  - Schemas (`docs/schemas/`)
  - Test fixtures (`tests/fixtures/`)
  - Validation test (`tests/test_cli_validate.py`)
- Templates and fixtures validated against schemas (see 2025-02-14 run).

## Key Artifacts for Review
- `README.md` – Updated setup instructions and command list.
- `docs/templates/*.json` – Sample inputs referencing JSON Schemas.
- `docs/schemas/*.schema.json` – Draft contracts mirroring Pydantic models.
- `tests/fixtures/events/BlacksvilleGA_2025/` – Canonical fixture set.
- `tests/test_cli_validate.py` – Regression test ensuring CLI validate works with fixtures.
- `docs/phases/0/status.md` – Ongoing status log.
- `docs/phases/parking-lot/README.md` – Deferred tasks queue.

## Outstanding & Deferred
- Reviewer note requested in Phase 0 status accomplished (this document).
- Deferred (parking lot):
  - GitHub Actions workflow for lint/type/test.
  - Makefile/Poetry shortcuts & VSCode tasks.
  - Extended documentation covering VSCode setup, CI overview, DevTools alignment.

## Risks & Assumptions
- CI not yet enforcing checks; rely on local runs per README.
- Radar ingestion expects canonical schema; adapters required for alternate formats (`docs/reference/testfile.json`).
- Phase 1 will depend on Excel parity extraction; ensure fixtures remain synchronized with templates when updating schemas.

## Next Phase Preview
- Phase 1 focus: Excel reverse engineering & parity tests (see `docs/phases/0/plan.md` roadmap).
- Priorities include `formula_graph.json` extraction, schema refinement, and expanded test coverage.

Please review artifacts above and confirm Phase 0 acceptance before proceeding.
